Astonea Labs rectifies FY25 filing discrepancies with BSE
- Astonea Labs addressed BSE queries regarding missing PDF formats for FY25 results
- The company resubmitted the mandatory Regulation 33(3) declaration to close pending records
- Original XBRL filings and board outcome documents remained valid prior to this update
- Revenue for FY25 was ₹9,751.83 lakh, with PAT at ₹535.05 lakh

*this image is generated using AI for illustrative purposes only.
Astonea Labs has submitted clarifications and rectifications to the Bombay Stock Exchange regarding pending discrepancies in its standalone financial results for FY25. The filing addresses observations raised by the exchange concerning missing document formats and regulatory declarations.
The company informed the BSE that while its FY25 results were originally submitted in XBRL mode and included in the board meeting outcome, the separate PDF version required under Regulation 33 of the SEBI (LODR) Regulations, 2015 was inadvertently omitted. Astonea Labs has now uploaded the requisite PDF to the exchange portal.
Regulatory Compliance Updates
The submission also resolves a query regarding the non-submission of the declaration under Regulation 33(3) of the SEBI (LODR) Regulations. The company stated it had previously submitted this declaration via email and the communication module in response to an earlier query from July 2025.
However, a separate announcement under the Corporate Announcements section was missed, keeping the query open on the portal. To facilitate closure and ensure complete compliance, Astonea Labs resubmitted the declaration along with relevant clarifications on September 19, 2026.
What the Numbers Show
The underlying financial data for FY25 remains unchanged by this procedural correction. Revenue from operations stood at ₹9,751.83 lakh for the year ended March 31, 2025, up from ₹8,019.09 lakh in the previous year. Profit after tax rose to ₹535.05 lakh compared to ₹407.01 lakh in FY24. The rectification filing solely pertains to documentation formalities rather than any revision of financial figures.
Historical Stock Returns for Astonea Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.92% | 0.0% | 0.0% | +128.78% | +103.74% | +161.33% |
Could these procedural lapses in regulatory filings signal broader internal control weaknesses that might affect future compliance or investor confidence?
How might this incident influence the Bombay Stock Exchange's scrutiny of Astonea Labs' subsequent quarterly filings and corporate announcements?
Given the strong FY25 revenue growth, will investors view this as a minor administrative error or a red flag regarding management's attention to detail?

































